Stifel raises Edwards Lifesciences stock to buy
Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core ...
GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”) ...
Edwards Lifesciences Corporation (NYSE ... As we noted earlier this year, the Company's flagship transcatheter aortic valve replacement (TAVR) franchise slowed as compared to the Company's ...
These techniques include coronary sinus annuloplasty, direct annuloplasty, leaflet repair ... (Edwards Lifesciences, Inc., CA, USA) valve is a balloon-expandable, bovine pericardial ...
News Medical on MSN3d
Mechanical valves offer superior long-term survival for aortic valve replacement patients agedAnnual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback